Share on LinkedInShare on LinkedIn

ARTICLE · 29 DECEMBER 2025

Market Intelligence Thought Leadership Award Winner

Navigating University Licenses And Industry Collaborations As A Swiss Biotech Startup

VISCHER
VISCHER
Contributor
VISCHER

VISCHER

VISCHER is one of the largest Swiss law firms, with more than 100 fee earners. The firm supports...

View firm profile
Explore more from VISCHER

Early‑stage biotech companies depend heavily on solid legal foundations, particularly in relation to their core technology.

SwitzerlandIntellectual Property

Early‑stage biotech companies depend heavily on solid legal foundations, particularly in relation to their core technology. Purposeful negotiation and structuring of license and collaboration agreements can strongly influence whether a promising discovery turns into a fundable, scalable business. This post distills practical insights, focusing on how founders can navigate Swiss university licensing practices and design industry collaborations that effectively protect and leverage their IP from day one.

From a University Lab Discovery to a Technology Licensed to a Spin‑off

A common scenario involves two researchers at a Swiss university who co-invent a life-science technology, which the university then patents and owns. The researchers subsequently establish a spin-off to acquire the rights to develop and commercialize this patented technology, forming the core of the spin-off's business. As the researchers plan on becoming founders, their collaboration with

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from